α7 nicotinic acetylcholine receptors in lung cancer (Review)
- Authors:
- Shengchao Wang
- Yue Hu
-
Affiliations: Department of Gynecological Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China, Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China - Published online on: May 30, 2018 https://doi.org/10.3892/ol.2018.8841
- Pages: 1375-1382
This article is mentioned in:
Abstract
 |
 |
|
Schwartz AG and Cote ML: Epidemiology of lung cancer. Adv Exp Med Biol. 893:21–41. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sher T, Dy GK and Adjei AA: Small cell lung cancer. Mayo Clin Proc. 83:355–367. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kuribayashi K, Funaguchi N and Nakano T: Chemotherapy for advanced non-small cell lung cancer with a focus on squamous cell carcinoma. J Cancer Res Ther. 12:528–534. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Zhao Y, Li C, Zhu L, Liu C and Liu L: The revision of 8th edition TNM stage criteria is more accurate in prediction postoperative survival for SCLC patients. Int J Surg. 48:83–85. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
American Cancer Society: Cancer facts and figures 2015. American Cancer Society; Atlanta, GA; 2015, https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2015/cancer-facts-and-figures-2015.pdf | |
|
Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H and Straif K; International Agency for Research on Cancer Monograph Working Group IARC: The carcinogenicity of outdoor air pollution. Lancet Oncol. 14:1262–1263. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Jemal A, Center MM, DeSantis C and Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kenfield SA, Wei EK, Stampfer MJ, Rosner BA and Colditz GA: Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control. 17:198–204. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Muscat JE, Stellman SD, Zhang ZF, Neugut AI and Wynder EL: Cigarette smoking and large cell carcinoma of the lung. Cancer Epidemiol Biomarkers Prev. 6:477–480. 1997.PubMed/NCBI | |
|
Couraud S, Zalcman G, Milleron B, Morin F and Souquet PJ: Lung cancer in never smokers-a review. Eur J Cancer. 48:1299–1311. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Schaal C and Chellappan S: Nicotine-mediated regulation of nicotinic acetylcholine receptors in non-small cell lung adenocarcinoma by E2F1 and STAT1 transcription factors. PLoS One. 11:e0156452016. View Article : Google Scholar | |
|
Cardinale A, Nastrucci C, Cesario A and Russo P: Nicotine: Specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol. 42:68–89. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dasgupta P, Rizwani W, Pillai S, Kinkade R, Kovacs M, Rastogi S, Banerjee S, Carless M, Kim E, Coppola D, et al: Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer. 124:36–45. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Puisieux A, Brabletz T and Caramel J: Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol. 16:488–494. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Improgo MR, Scofield MD, Tapper AR and Gardner PD: The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: Dual role in nicotine addiction and lung cancer. Prog Neurobiol. 92:212–226. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sargent PB: The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci. 16:403–443. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Lukas RJ, Changeux JP, Le Novère N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, et al: International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev. 51:397–401. 1999.PubMed/NCBI | |
|
Dani JA and Bertrand D: Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxico. 47:699–729. 2007. View Article : Google Scholar | |
|
Papke RL, Bagdas D, Kulkarni AR, Gould T, AlSharari SD, Thakur GA and Damaj MI: The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor. Neuropharmacology. 91:34–42. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Arias HR, Richards VE, Ng D, Ghafoori ME, Le V and Mousa SA: Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis. Int J Biochem Cell Biol. 41:1441–1451. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Russo P and Taly A: α7-Nicotinic acetylcholine receptors: An old actor for new different roles. Curr Drug Targets. 13:574–578. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Egleton RD, Brown KC and Dasgupta P: Nicotinic acetylcholine receptors in cancer: Multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci. 29:151–158. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng Y, Ritzenthaler JD, Roman J and Han S: Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. Am J Respir Cell Mol Biol. 37:681–690. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Schuller HM: Regulatory role of the α7nAChR in cancer. Curr Drug Targets. 13:680–687. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Singh S, Pillai S and Chellappan S: Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol. 2011:4567432011. View Article : Google Scholar : PubMed/NCBI | |
|
Pillai S and Chellappan S: α7 nicotinic acetylcholine receptor subunit in angiogenesis and epithelial to mesenchymal transition. Curr Drug Targets. 13:671–679. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang C, Ding XP, Zhao QN, Yang XJ, An SM, Wang H, Xu L, Zhu L and Chen HZ: Role of α7-nicotinic acetylcholine receptor in nicotine-induced invasion and epithelial-to-mesenchymal transition in human non-small cell lung cancer cells. Oncotarget. 7:59199–59208. 2016.PubMed/NCBI | |
|
Seifert U, Schlanstedt-Jahn U and Klug SJ: Screening for cancer. Internist (Berl). 56:1114–1123. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
National Cancer Institute: SEER cancer statistics review, 1975–2011. https://seer.cancer.gov/archive/csr/1975_2011/Updated December 17. 2014 | |
|
Warren GW and Cummings KM: Tobacco and lung cancer: Risks, trends, and outcomes in patients with cancer. Am Soc Clin Oncol Educ Book:. pp. 359–364. 2013, View Article : Google Scholar : PubMed/NCBI | |
|
Hecht SS: Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 3:733–744. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Whitrow MJ, Smith BJ, Pilotto LS, Pisaniello D and Nitschke M: Environmental exposure to carcinogens causing lung cancer: Epidemiological evidence from the medical literature. Respirology. 8:513–521. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health: The health consequences of smoking-50 years of progress: A report of the surgeon general. Centers for Disease Control and Prevention (US). Atlanta, GA; 2014 | |
|
Jha P: Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer. 9:655–664. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wessler I and Kirkpatrick CJ: Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Br J Pharmacol. 154:1558–1571. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cattaneo MG, D'Atri F and Vicentini LM: Mechanisms of mitogen-activated protein kinase activation by nicotine in small-cell lung carcinoma cells. Biochem J. 328:499–503. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Song P, Sekhon HS, Proskocil B, Blusztajn JK, Mark GP and Spindel ER: Synthesis of acetylcholine by lung cancer. Life Sci. 72:2159–2168. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Song P, Sekhon HS, Lu A, Arredondo J, Sauer D, Gravett C, Mark GP, Grando SA and Spindel ER: M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res. 67:3936–3944. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zou W and Chen L: Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol. 8:467–477. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Song P, Sekhon HS, Fu XW, Maier M, Jia Y, Duan J, Proskosil BJ, Gravett C, Lindstrom J, Mark GP, et al: Activated cholinergic signaling provides a target in squamous cell lung carcinoma. Cancer Res. 68:4693–4700. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Song P, Sekhon HS, Jia Y, Keller JA, Blusztajn JK, Mark GP and Spindel ER: Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res. 63:214–221. 2003.PubMed/NCBI | |
|
Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E and Chellappan S: Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA. 103:6332–6337. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E and Chellappan S: Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest. 16:2208–2217. 2006. View Article : Google Scholar | |
|
Lam DC, Girard L, Ramirez R, Chau WS, Suen WS, Sheridan S, Tin VP, Chung LP, Wong MP, Shay JW, et al: Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res. 67:4638–4647. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Brown KC, Perry HE, Lau JK, Jones DV, Pulliam JF, Thornhill BA, Crabtree CM, Luo H, Chen YC and Dasgupta P: Nicotine induces the up-regulation of the α7-nicotinic receptor (α7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway. J Biol Chem. 288:33049–33059. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bordas A, Cedillo JL, Arnalich F Esteban-Rodriguez I, Guerra-Pastrián L, de Castro J, Martín-Sánchez C, Atienza G, Fernández-Capitan C, Rios JJ and Montiel C: Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers. Oncotarget. 8:67878–67890. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Paleari L, Catassi A, Ciarlo M, Cavalieri Z, Bruzzo C, Servent D, Cesario A, Chessa L, Cilli M, Piccardi F, et al: Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Cell Prolif. 41:936–959. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D and Chellappan S: Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One. 4:e75242009. View Article : Google Scholar : PubMed/NCBI | |
|
Medjber K, Freidja ML, Grelet S, Lorenzato M, Maouche K, Nawrocki-Raby B, Birembaut P, Polette M and Tournier JM: Role of nicotinic acetylcholine receptors in cell proliferation and tumour invasion in broncho-pulmonary carcinomas. Lung Cancer. 87:258–264. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Wadei HA, Al-Wadei MH and Schuller HM: Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: A novel target for intervention. PLoS One. 7:e299152012. View Article : Google Scholar : PubMed/NCBI | |
|
Zovko A, Viktorsson K, Lewensohn R, Kološa K, Filipič M, Xing H, Kem WR, Paleari L and Turk T: APS8, a polymeric alkylpyridinium salt blocks α7 nAChR and induces apoptosis in non-small cell lung carcinoma. Mar Drugs. 11:2574–2594. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Paleari L, Sessa F, Catassi A, Servent D, Mourier G, Doria-Miglietta G, Ognio E, Cilli M, Dominioni L, Paolucci M, et al: Inhibition of non-neuronal alpha7-nicotinic receptor reduces tumorigenicity in A549 NSCLC xenografts. Int J Cancer. 125:199–211. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Grozio A, Paleari L, Catassi A, Servent D, Cilli M, Piccardi F, Paganuzzi M, Cesario A, Granone P, Mourier G and Russo P: Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: A promising prospective in anti-cancer drug development. Int J Cancer. 122:1911–1915. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sheppard BJ, Williams M, Plummer HK and Schuller HM: Activation of voltage-operated Ca2+-channels in human small cell lung carcinoma by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Int J Oncol. 16:513–518. 2000.PubMed/NCBI | |
|
Jull BA, Plummer HK III and Schuller HM: Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol. 127:707–717. 2001.PubMed/NCBI | |
|
Hung YH and Hung WC: 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) enhances invasiveness of lung cancer cells by up-regulating contactin-1 via the alpha7 nicotinic acetylcholine receptor/ERK signaling pathway. Chem Biol Interact. 179:154–159. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong X, Fan Y, Ritzenthaler JD, Zhang W, Wang K, Zhou Q and Roman J: Novel link between prostaglandin E2 (PGE2) and cholinergic signaling in lung cancer: The role of c-Jun in PGE2-induced α7 nicotinic acetylcholine receptor expression and tumor cell proliferation. Thorac Cancer. 6:488–500. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sun X, Ritzenthaler JD, Zhong X, Zheng Y, Roman J and Han S: Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha. Cancer Res. 69:6445–6453. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chernyavsky AI, Shchepotin IB and Grando SA: Mechanisms of growth-promoting and tumor-protecting effects of epithelial nicotinic acetylcholine receptors. Int Immunopharmacol. 29:36–44. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Brown KC, Lau JK, Dom AM, Witte TR, Luo H, Crabtree CM, Shah YH, Shiflett BS, Marcelo AJ, Proper NA, et al: MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway. Angiogenesis. 15:99–114. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shen J, Xu L, Owonikoko TK, Sun SY, Khuri FR, Curran WJ and Deng X: NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop. Cancer Lett. 318:106–113. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Iskandar AR, Miao B, Li X, Hu KQ, Liu C and Wang XD: β-cryptoxanthin reduced lung tumor multiplicity and inhibited lung cancer cell motility by downregulating nicotinic acetylcholine receptor α7 signalingg. Cancer Prev Res (Phila). 9:875–886. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang C, Yu P, Zhu L, Zhao Q, Lu X and Bo S: Blockade of α7 nicotinic acetylcholine receptors inhibit nicotine-induced tumor growth and vimentin expression in non-small cell lung cancer through MEK/ERK signaling way. Oncol Rep. 38:3309–3318. 2017.PubMed/NCBI | |
|
Mucchietto V, Fasoli F, Pucci S, Moretti M, Benfante R, Maroli A, Di Lascio S, Bolchi C, Pallavicini M, Dowell C, et al: α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line. Br J Pharmacol. Jul 20. 2017, (Epub ahead of print). PubMed/NCBI | |
|
Yan Y, Su C1, Hang M, Huang H, Zhao Y, Shao X and Bu X: Recombinant Newcastle disease virus rL-RVG enhances the apoptosis and inhibits the migration of A549 lung adenocarcinoma cells via regulating alpha 7 nicotinic acetylcholine receptors in vitro. Virol J. 14:1902017. View Article : Google Scholar : PubMed/NCBI | |
|
Paleari L, Cesario A, Fini M and Russo P: alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma? Drug Discov Today. 14:822–836. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Cavallaro U and Christofori G: Molecular mechanisms of tumor angiogenesis and tumor progression. J Neurooncol. 50:63–70. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Wu MY, Li CJ, Yiang GT, Cheng YL, Tsai AP, Hou YT, Ho YC, Hou MF and Chu PY: Molecular regulation of bone metastasis pathogenesis. Cell Physiol Biochem. 46:1423–1438. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Clark AG and Vignjevic DM: Modes of cancer cell invasion and the role of the microenvironment. Curr Opin Cell Biol. 36:13–22. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shenker RF, McTyre ER, Ruiz J, Weaver KE, Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR, Watabe K, et al: The Effects of smoking status and smoking history on patients with brain metastases from lung cancer. Cancer Med. 6:944–952. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Warren GW, Sobus S and Gritz ER: The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. Lancet Oncol. 15:e568–e580. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gopalakrishna R, Chen ZH and Gundimeda U: Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells. Proc Natl Acad Sci USA. 91:12233–12237. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshino I and Maehara Y: Impact of smoking status on the biological behavior of lung cancer. Surg Today. 37:725–734. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Schuller HM: Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res. 39:45–63. 2007. View Article : Google Scholar : PubMed/NCBI |
